European Archives - Page 68 of 1208 - European Medical Journal

Acne Treatment Review and Present Perspectives

Acne is a chronic inflammatory skin disease whose visible effects can have a significant psychological impact on patients. A multimodal…

Which COPD Inhaler Device?

Inhalation therapy is central to the treatment of patients with COPD, a condition that affects an estimated 480 million people;…

Spotlight on Becker

This infographic presents an overview of Becker Muscular Dystrophy outlining the disease itself, exploring the diagnosis of the disease…

The Value of Patient Engagement in Preventive Medicine

In the context of increasing healthcare complexity and chronic disease prevalence, patient engagement is gaining recognition as a key…

Characterising Drug-Associated Nephrolithiasis

Kidney stones are the most common condition affecting the urinary system, impacting approximately 8–12% of the global population…

Nanomedicine in Diabetes Treatment: Novel Drug Delivery Systems

Diabetes is a chronic metabolic disorder characterised by persistently high blood sugar levels (hyperglycaemia) caused by deficiencies…

Target-Like Lesions with Mucositis Due to Co-Infection with Mycoplasma pneumoniae and Varicella-Zoster Virus

Cases involving co-infections with Mycoplasma pneumoniae and varicella-zoster virus (VZV) are exceedingly rare in medical literature…

Oesophageal Actinomycosis Masquerading as Squamous Cell Carcinoma

The Actinomyces family includes 47 different species. Actinomycosis infections are characterised by abscess formation, granulation…

UK to raise branded drug repayment rate to over 30%

The UK will hike statutory payment rates for branded drugs to over 30% in 2025, far surpassing other European markets and raising concerns.

Education or promotion: What wins with HCPs?

When every second of a healthcare professional’s time counts, what content truly earns their attention – disease awareness or product promotion?